Stephen K. Frankel, MD, is a pulmonologist at National Jewish Health. Dr. Frankel serves as the Executive Vice President of Clinical Affairs.
Patient Ratings
5 out of 5
Programs and Services
Specialties & Conditions
- Autoimmune Lung Diseases
- Interstitial Lung Disease (ILD)/Pulmonary Fibrosis
- Vasculitis
Special Interests
Dr. Frankel’s primary focus is how to provide our patients with the highest quality, patient-centered care anywhere, reliably, efficiently, and consistent with the “National Jewish way.” He is committed to making sure our patients received both evidence-based best practice and individualized, precision medicine. Dr. Frankel works closely with all of our care partners and inpatient facilities to assure that our patients are cared for throughout the entire continuum of care, both inpatient and outpatient, and that careful attention is paid to the transitions between these domains and care coordination. Ultimately, Dr. Frankel’s core mission is making sure we meet the care needs of our patients and our community.
Academically, Dr. Frankel is a nationally-recognized expert in interstitial lung diseases and vasculitis, and he is an integral part of the National Jewish Interstitial Lung Disease Program. Over the course of his career he has been involved in basic science, translational and clinical research in both interstitial lung disease and critical care medicine. Presently, his primary academic focus is on health service delivery, continuous quality improvement, and health care policy.
Education
Education
- 1991 - 1995
- Harvard Medical School, Harvard University, MD
- 1987 - 1991
- Harvard College, Harvard University, BA, Biology
Residency
- 1995 - 1998
- Beth Israel Hospital (Boston, MA), Internship and Residency, Internal Medicine
Fellowship
- 1998 - 2001
- University of Colorado Denver, Pulmonary and Critical Care Medicine
Awards & Recognition
2007-2014: Top Doctor, Critical Care Medicine, 5280 Magazine
2012: Citizen of the Year, National Jewish Health
2010-2012: Chair, Steering Committee, Interstitial and Diffuse Lung Disease Network, American College of Chest Physicians
Board Certification
Internal Medicine
Pulmonary Medicine
Critical Care Medicine
Professional Memberships
CHEST (American College of Chest Physicians), Fellow
American College of Critical Care Medicine, Fellow
Publications
Frankel, S.K., and Moss, M. (2014) The Effect of Organizational Structure and Processes of Care on ICU Mortality as Revealed by the United States Critical Illness and Injury Trials Group Critical Illness Outcomes Study. Crit Care Med. 42(2): 463-4. PMID: 24434451.
Fischer, A., Brown K.K., DuBois, R.M., Frankel, S.K., Cosgrove, G.P., Fernandez-Perez, E.R., Huie, T.J., Krishnamoorthy, M., Meehan, R.T., Olson, A.L., Solomon, J.J., Swigris, J.J. (2013) Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease. J Rheumatol. Mar 1 40(5): 640-646. PMID 23457378.
Fernandez-Perez, E.R and Frankel, S.K. (2013) Eosinophilic Lung Diseases. Clinical Pulmonary Medicine. 20:280-291.
Frankel, S. K. and Schwarz, M.I. (2012) Concise Clinical Review of the Pulmonary Vasculitides. Am J Respir Crit Care Med 186: 216-224. PMID 22679011.
Huie, T. J, Olson, A. L., Cosgrove, G. P., Janssen, W. J., Lara, A. R., Lynch, D. A., Groshong, S. D., Moss, M., Schwarz, M. I., Brown, K. K., and Frankel, S.K (2010) A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes. Respirology: 15(6) 909-917. PMID: 20546190.
Hospital Affiliations
- Colorado Acute Long Term Hospital
- Denver Health Medical Center
- Rose Medical Center
- St. Joseph Hospital - Denver
- Swedish Medical Center
- University of Colorado Hospital
Academic Affiliations
Professor, Division of Pulmonary Sciences & Critical Care Medicine, Department of Medicine
Conflicts of Interest
National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.
The Patient metric-rating score is an average of all responses to
care provider related questions on our independent metric-rating
system, the Press Ganey Patient Satisfaction Survey. This survey is
about the patient care experience and does not address crucial
characteristics like medical decision-making, prescribing the best
therapy, and patient outcomes.
